Welcome to our dedicated page for Purple Innovatio news (Ticker: PRPL), a resource for investors and traders seeking the latest updates and insights on Purple Innovatio stock.
Purple Innovation, Inc. reports developments around its branded sleep-products business, built on GelFlex Grid technology and sold through e-commerce, wholesale partners, company showrooms, and third-party online retailers. News commonly covers quarterly revenue and margin performance, adjusted EBITDA, showroom comparable sales, e-commerce trends, and wholesale distribution with retail partners.
Company updates also address product and brand momentum across mattresses, pillows, bedding, and cushions, including premium mattress lines such as Purple Royale and Rejuvenate 2.0. Other recurring subjects include operating-efficiency initiatives, debt amendments, earnings-call schedules, and leadership or finance-function changes.
Purple Innovation (NASDAQ: PRPL) reported Q1 2026 results: net revenue $95.7M (down 8.1% YoY) and gross profit $35.2M (36.8% margin). Showroom comps rose 7.0% for a third consecutive quarter and ecommerce trends improved sequentially. Adjusted EBITDA was $(4.8)M; net loss attributable to company was $30.5M. Cash totaled $25.0M and inventories were $58.1M. The company lowered full-year revenue guidance to $465–$485M and maintained adjusted EBITDA guidance of $20–$30M. A conference call and webcast were scheduled for April 28, 2026.
Purple Innovation (NASDAQ: PRPL) announced a CFO transition on April 28, 2026: Todd Vogensen will depart effective May 1, 2026, and Robert (Bob) Lucian was appointed Chief Financial Officer effective April 27, 2026. Lucian joins from La-Z-Boy with prior roles at Coty and Procter & Gamble.
Management says the move aligns with its financial improvement plan and highlights Lucian's retail, manufacturing, and branded-consumer experience as relevant to Purple's next phase.
Purple Innovation (NASDAQ: PRPL) will report first quarter 2026 results on April 28, 2026 at approximately 8:00 a.m. ET and host a conference call at 8:30 a.m. ET.
Investors may join by phone (800-715-9871 domestic; 646-307-1963 international, Conference ID 7609054) or via a live webcast at investors.purple.com. A replay will remain available on the investor relations website for one year.
Purple Innovation (NASDAQ: PRPL) reported fourth-quarter 2025 revenue of $140.7M, up ~9.1%, and GAAP net loss of $3.2M. Adjusted EBITDA was $8.8M in Q4 and $1.9M for full-year 2025. Full-year revenue was $468.7M, down 3.9%.
Gross margin improved to 40.2% for 2025 and 41.9% in Q4. Cash totaled $24.3M at year-end. 2026 guidance: revenue $500–$520M and adjusted EBITDA $20–$30M; Q1 2026 revenue guide of $100–$105M with adjusted EBITDA of $(7)–$(4)M.
Purple Innovation (NASDAQ: PRPL) extended its debt maturity from December 31, 2026 to April 30, 2027 and rescheduled its fourth-quarter and full-year 2025 financial release and conference call.
The company now expects to file its Form 10-K and release results on March 31, 2026 at ~8:00 a.m. ET, with a conference call at 8:30 a.m. ET and a webcast replay available for one year.
Purple Innovation (NASDAQ: PRPL) will report fourth quarter and full year 2025 financial results on March 25, 2026 at approximately 8:00 a.m. ET. The company will host a conference call at 8:30 a.m. ET with dial-in and live webcast options.
A telephone replay is available through April 1, 2026, and a webcast replay will remain on the investor relations site for one year. Investors should register on the webcast site at least 15 minutes before the call.
Purple (NASDAQ: PRPL) announced independent SleepScore Labs studies showing Purple Essentials and Purple Restore mattresses with GelFlex Grid reduced self-reported nighttime pain disruptions and improved measured sleep across two 10-week, in-home trials covering >3,300 nights.
Key results: pain reductions of 68% (Essentials) and 63% (Restore); Essentials users fell asleep 8% faster and woke 6% less often; Restore users gained +3.5 hours deep sleep/month and +7 hours total sleep/month, with sleep quality +3% and efficiency +2%. Self-reported morning restoration and satisfaction rose substantially for both collections.
Purple (NASDAQ: PRPL) announced results from two independent 10-week, in-home SleepScore Labs studies of its Essentials and Restore mattresses with GelFlex Grid technology.
Across more than 3,300 nights of objective and self-reported data, participants reported nighttime pain reductions of 68% (Essentials) and 63% (Restore), plus large gains in morning restoration, sleep quality, and satisfaction (Essentials: +90%–+127%; Restore: +170%–+214%). Objectively measured changes included faster sleep onset (Essentials) and more deep sleep and longer monthly sleep time (Restore).
Interested partners can discuss the findings at Purple's Las Vegas Winter Market showroom on January 26, 2026.
Purple Innovation (NASDAQ: PRPL) reported third quarter 2025 results on Nov 4, 2025, highlighting a continued profitability turnaround. Q3 net revenue was $118.8M versus $118.6M year‑ago. Gross profit rose to $50.9M (42.8% of revenue) and adjusted gross margin expanded by 230 basis points vs. the prior year. Operating expense fell 23.2% to $63.0M. Net loss narrowed to $11.7M from $39.2M, and adjusted EBITDA improved to $0.2M from $(6.4)M. Cash was $32.4M and net inventories were $65.8M (up 9.8% YoY). The company maintained full‑year 2025 guidance: $465–$485M revenue and adjusted EBITDA breakeven to $10M.
Management cited Rejuvenate 2.0, Mattress Firm rollout, showroom strength and manufacturing efficiencies as drivers of momentum while e‑commerce remained softer.
Purple Innovation (NASDAQ: PRPL) will report third quarter 2025 financial results on Tuesday, November 4, 2025 at approximately 4:05 p.m. ET.
The company will host a conference call at 4:30 p.m. ET the same day; domestic dial-in is 800-715-9871, international dial-in is 646-307-1963, Conference ID 7609054. A live webcast will be available at investors.purple.com (register at least 15 minutes early).
A telephone replay is available until November 11, 2025 at 800-770-2030 with Conference ID 7609054, and a webcast replay will remain on the investor relations site for one year.